News

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
India Inc's Q4 earnings season intensifies with 81 firms, including ITC, Sun Pharma, ONGC, and Hindalco, set to report this week, offering insights into sectoral performance and future growth outlooks ...
Defence sector, IndusInd Bank Ltd., and Piramal Pharmaceuticals Ltd. were among the top companies on brokerages' radar on Friday. According to Jefferies, focus on defence indigenisation since ...
Their responses insult those investors’ intelligence. On Wednesday, we got a doozy from Mayne Pharma, an ASX 300 drug company big enough and listed for long enough to know better. Despite ...
The pharmaceutical industry in Ireland was last night trying to work out the potential impact of US President Donald Trump’s vow to force European countries to pay higher drug prices while ...
President Trump's "most favored nation" policy aims to drastically lower U.S. prescription drug prices by aligning them with the lowest international rates, impacting global pharmaceutical markets ...
"Government price setting in any form is bad for American patients," Alex Schriver, a spokesperson for the top U.S. drug company lobbying group, the Pharmaceutical Research and Manufacturers of ...
Shares in the pharmaceutical sector have come under heavy pressure worldwide due to concerns about profitability in the US business. US President Donald Trump wants to lower prices for ...
May 12 (Reuters) - Indian pharma stocks (.NIPHARM), opens new tab fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug prices by 30%–80% to match ...
effectively conveys the level of risk of side effects to people taking a medicine. Design: Randomised controlled study with unconcealed allocation. Participants: 120 adults taking simvastatin or ...
Editors’ Note: On December 17, 2020, the New England Journal of Medicine published a research letter ... racial justice work that already made corrections for its biased design? None that he’d heard ...
The body has assured that it will coordinate with pharmaceutical companies to resolve supply issues swiftly and avoid any break in the availability of quality medicines. “In times of need, the ...